Skip to content
Zenith Health Care logo

Zenith Health Care

530665 BSE
Price unavailable

Zenith Health Care (ZENITHHE) share price was ₹3.61 at the 28 Oct 2026 close; market capitalisation ₹19.36 Cr; P/E (TTM) 90.25; sector Healthcare. The share price fell 8.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 8.9% year on year to ₹3.43 Cr and net profit was ₹0.14 Cr, against −₹0.02 Cr a year earlier (compared with Jun 2025). Promoters held 28.74% of Zenith Health Care in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 39/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹3.61 −0.35 −8.84% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹19.36 Cr
P/E (TTM)
90.25
EBITDA
₹30.00 L
Return on Equity
0.07%
Debt to Equity
0
Book Value
₹1.38
EPS (TTM)
₹0.04
52W High
₹4.12
52W Low
₹2.23

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.7035.054,23,891 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,610.8072.381,75,380 Cr9.550.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.80108.091,18,210 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.4034.661,11,714 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.2032.711,10,289 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Zenith Health Care (this company)
—90.2519 Cr2.620.00%0.07%0.33%11 Cr0 Cr
Median 8 companies₹1,766.7053.721,18,022 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

39 Weak
Overall score

Data confidence 98/100

Category scores

Quality Poor 28
Returns, margins, earnings quality 22% weight
Valuation Poor 20
Cheap vs sector & own history 24% weight
Growth Poor 26
Sales & profit trajectory 9% weight
Financial Health Strong 68
Solvency, leverage, coverage 9% weight
Momentum Strong 76
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -5.20% over past five years.
  • Promoter holding is low: 28.7%
  • Company has a low return on equity of 0.77% over last 3 years.
  • Working capital days have increased from 84.2 days to 122 days

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bullish

Bearish
2
Neutral
5
Bullish
12

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
-7.63% lower than 3Y

change over 1 year

Net Income Growth
-100% lower than 3Y

change over 1 year

Cash Flow Change
-251%

change over 1 year

EBITDA Margin Change
-41.8%

change over 1 year Operating margin 4.96% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4.07
3.49
3.89
3.07
2.57
3.03
2.31
3.43
3.15
2.27
2.48
2.62
3.43
Expenses
3.76
3.36
3.79
3.31
2.45
2.89
2.51
3.41
3.29
2.1
2.2
3.08
3.26
Operating Profit
0.31
0.13
0.1
-0.24
0.12
0.14
-0.2
0.02
-0.14
0.17
0.28
-0.46
0.17
OPM %
7.62%
3.72%
2.57%
-7.82%
4.67%
4.62%
-8.66%
0.58%
-4.44%
7.49%
11.29%
-17.56%
4.96%
Other Income
0
0.04
0.06
0.11
0.08
0.08
0.16
0.11
0.17
0.11
0.04
0.1
0.07
Interest
0
0
0.01
0
0
0
0
0
0
0
0
0
0
Depreciation
0.05
0.06
0.05
0.05
0.04
0.04
0.07
0.08
0.06
0.07
0.07
0.06
0.06
PBT
0.26
0.11
0.1
-0.18
0.16
0.18
-0.11
0.05
-0.03
0.21
0.25
-0.42
0.18
Tax %
0%
0%
0%
38.89%
0%
44.44%
172.73%
-120%
-33.33%
38.1%
8%
-19.05%
22.22%
Net Profit
0.26
0.12
0.1
-0.26
0.16
0.09
-0.29
0.11
-0.02
0.14
0.22
-0.34
0.14
EPS (₹)
0.05
0.02
0.02
-0.05
0.03
0.02
-0.05
0.02
0
0.03
0.04
-0.06
0.03
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3.64
3.46
4.79
9.51
9.83
11.98
13.74
22.36
13.13
14.47
11.33
10.52
10.8
Expenses
3.68
3.69
4.73
8.95
9.63
11.43
13.38
21.91
13.1
14.23
11.24
10.65
10.64
Operating Profit
-0.04
-0.23
0.06
0.56
0.2
0.55
0.36
0.45
0.03
0.24
0.09
-0.13
0.16
OPM %
-1.1%
-6.65%
1.25%
5.89%
2.03%
4.59%
2.62%
2.01%
0.23%
1.66%
0.79%
-1.24%
1.48%
Other Income
0.05
0.12
0.08
0.13
0.21
0.3
0.46
0.52
0.38
0.26
0.43
0.41
0.32
Interest
0.01
0.01
0.01
0.01
0
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
Depreciation
0.35
0.35
0.3
0.28
0.25
0.25
0.25
0.36
0.28
0.21
0.23
0.26
0.26
PBT
-0.35
-0.47
-0.17
0.4
0.16
0.59
0.56
0.6
0.12
0.28
0.28
0.01
0.22
Tax %
-31.43%
-36.17%
-11.76%
32.5%
18.75%
3.39%
19.64%
48.33%
33.33%
25%
78.57%
200%
—
Net Profit
-0.24
-0.31
-0.15
0.27
0.14
0.57
0.44
0.31
0.08
0.2
0.07
0.01
0.16
EPS (₹)
-0.04
-0.06
-0.03
0.05
0.03
0.11
0.08
0.06
0.01
0.04
0.01
0
0.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
5.37
Reserves
0.48
0.17
0.02
0.29
0.43
1.03
1.47
1.78
1.86
1.96
2.03
2.05
Borrowings
0
0
0
0
0.02
0
0
0
0
0
0
0
Other Liabilities
0.6
1.04
0.74
1.43
1.14
2.14
1.92
4.52
2.02
2.56
3.48
3.56
Total Liabilities
6.45
6.58
6.13
7.09
6.96
8.54
8.76
11.67
9.25
9.89
10.88
10.98
Fixed Assets
2.17
1.93
1.75
1.81
1.62
1.7
1.8
1.75
1.5
1.4
1.55
1.45
CWIP
0
0
0
0
0
0.17
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0.01
Other Assets
4.28
4.65
4.38
5.28
5.34
6.67
6.96
9.92
7.75
8.49
9.33
9.52
Total Assets
6.45
6.58
6.13
7.09
6.96
8.54
8.76
11.67
9.25
9.89
10.88
10.98
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.19
0.23
0.23
0
-0.06
1.95
-1.47
1.32
-0.92
1.74
0.55
-0.83
Investing
-0.14
0.01
-0.12
0
-0.05
-0.5
-0.19
-0.23
-0.03
-1.88
-0.96
0.85
Financing
0
0
0
0
0.02
-0.02
0
0
0
0
-0.01
-0.01
Net Cash Flow
0.05
0.24
0.11
0
-0.09
1.44
-1.65
1.09
-0.95
-0.14
-0.41
0.01
Free Cash Flow
-0.18
0.11
0.11
0
-0.11
1.45
-1.66
1.08
-0.95
1.63
0.16
-0.99
CFO/OP
-475
-100
383
0
-15
356
-372
333
-2,967
796
667
615
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
184
133
84.58
54.88
33.79
31.08
44.89
53.05
64.22
57.26
77.96
72.51
Inventory Days
171
297
180
103
126
99.18
145
105
147
86.65
153
220
Days Payable
86.27
178
78.95
82.53
47.61
84.31
71.22
37.63
51.11
38.08
92.93
115
Cash Conversion Cycle
268
253
186
75.01
112
45.95
119
120
161
106
138
177
Working Capital Days
247
209
136
82.13
96.17
48.14
98.02
50.93
117
60.54
69.91
122
ROCE %
-5.71%
-8.08%
-2.93%
7.42%
2.79%
9.82%
8.61%
8.72%
1.81%
3.98%
3.12%
0.27%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zenith Health Care insights

64 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

DIIs0.39%Public63.87%Others7.00%Promot.28.74%As ofSep 2026

Documents

Frequently Asked Questions about Zenith Health Care

What does Zenith Health Care Ltd do?
Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products[1]
Where is Zenith Health Care Ltd (ZENITHHE) listed?
Zenith Health Care Ltd trades under code 530665 on the BSE.
Which sector does Zenith Health Care Ltd belong to?
Zenith Health Care Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Zenith Health Care Ltd?
Zenith Health Care Ltd has a market capitalisation of ₹19.36 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Zenith Health Care Ltd?
Zenith Health Care Ltd trades at a PE ratio of 90.25 as of 28 Oct 2026, on earnings per share of ₹0.04, against a book value of ₹1.38 per share.
What is the 52-week high and low of Zenith Health Care Ltd?
Over the last 52 weeks Zenith Health Care Ltd has traded between ₹2.23 and ₹4.12 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Zenith Health Care Ltd?
Zenith Health Care Ltd reported a return on equity of 0.07%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products[1]

Website zenithhealthcare.com
Face Value ₹ 1
Shares Outstanding 5,36,42,384

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530665.md for Zenith Health Care Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month